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The pulmonary outcome of long-term survivors after congenital
diaphragmatic hernia repair
Abstract
BACKGROUND: Congenital diaphragmatic hernia (CDH) represents a chronic condition with
significant pulmonary and non-pulmonary complications. The main aim of the present study was to
determine the pulmonary outcome in a group of long-term survivors of CDH. METHODS: Clinical
records of 46 patients with CDH admitted to the University Children's Hospital Zurich between 1991
and 2001 were reviewed retrospectively. Survivors underwent clinical examination, lung function tests
and measurements of exhaled nitric oxide. RESULTS: 30 of 46 (65%) patients survived after repair of
CDH and 19 children participated in a follow-up study at the mean age of 7.9 (2.8) years. At least one
wheezy episode requiring inhaled bronchodilators was reported by 9/19 (47%) children and 4/19 (21%)
children complained of recurrent wheezy episodes. Nine children showed lung function impairment in
spirometry as well as in oscillatory resistance. Neither duration of assisted ventilation nor the length of
hospitalisation appeared to correlate with lung function. Exhaled nitric oxide was within normal range in
our group of CDH survivors. Measurement of respiratory system resistance using a forced oscillation
technique detected those CDH survivors, who showed abnormal pattern in spirometry. However, no
correlation between oscillatory resistance and specific airway resistance measured by whole body
plethysmography was found. CONCLUSIONS: Despite the presence of rather insignificant symptoms,
we found mild to moderate pulmonary functional impairment in children surviving CDH repair.
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Background: Congenital diaphragmatic hernia
(CDH) represents a chronic condition with signif -
icant pulmonary and non-pulmonary complica-
tions. The main aim of the present study was to
determine the pulmonary outcome in a group of
long-term survivors of CDH. 
Methods: Clinical records of 46 patients with
CDH admitted to the University Children’s Hos-
pital Zurich between 1991 and 2001 were reviewed
retrospectively. Survivors underwent clinical exam-
i nation, lung function tests and measurements of
exhaled nitric oxide. 
Results: 30 of 46 (65%) patients survived after
repair of CDH and 19 children participated in a
follow-up study at the mean age of 7.9 (2.8) years.
At least one wheezy episode requiring inhaled
bronchodilators was reported by 9/19 (47%) chil-
dren and 4/19 (21%) children complained of re-
current wheezy episodes. 
Nine children showed lung function impair-
ment in spirometry as well as in oscilla tory resist-
ance. Neither duration of assisted ventilation nor
the length of hospitalisation appeared to corre-
late with lung function. Exhaled nitric oxide was
within normal range in our group of CDH sur-
vivors.
Measurement of respiratory system resistance
using a forced oscillation technique detected
those CDH survivors, who showed abnormal pat-
tern in spirometry. However, no correlation be-
tween oscillatory resistance and specific airway
resistance measured by whole body plethysmog-
raphy was found.  
Conclusions: Despite the presence of rather in-
significant symptoms, we found mild to moderate
pulmonary functional impairment in children sur-
viving CDH repair. 
Key words: congenital diaphragmatic hernia; lung
function; forced oscillation technique; exhaled nitric
oxide
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Abbreviation list
BPD bronchopulmonary dysplasia
CDH congenital diaphragmatic hernia
ECMO extracorporeal membrane oxygenation 
ERS European Respiratory Society 
FEV1 Forced expiratory volume in 1st second
FOT forced oscillation technique
FVC forced vital capacity
GER gastroesophageal reflux
HFOV high-frequency oscillation ventilation
iNO inhaled nitric oxide 
ITGV intra-thoracic gas volume
MCH methacholine
MEF75 maximum expiratory flow at 75%, 50% and at 25% 
MEF50 of vital capacity 
MEF25
PEF peak expiratory flow 
R tot total resistance 
Rrs resistance of respiratory system
RV residual volume 
SR tot total specific airway resistance
TLC total lung capacity 
VC vital capacity
Xrs reactance of respiratory system
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Congenital diaphragmatic hernia (CDH) refers
to a defect in the diaphragm that allows abdominal
organs to move into the chest cavity. Depending
on the timing of the herniation and the volume 
of abdominal organs involved, this defect has the
potential to disrupt normal lung development.
Delayed operative repair [1], inhaled nitric oxide
(iNO) [2], high-frequency oscillation ventilation
(HFOV) [3], gentle ventilation with permissive
hypercapnia [4] and extracorporeal membrane
oxygenation (ECMO) [5] have resulted in an in-
creased survival. Chronic pulmonary disease, feed-
ing problems including gastroesophageal reflux
[6], orthopaedic problems such as scoliosis [7] and
neurological complications [8] represent the major
causes of morbidity in CDH survivors today.
The aim of the present study was to evaluate
the long-term pulmonary morbid ity in children
who had undergone repair of a CDH during a 
ten-year period in a tertiary centre in Switzerland. 
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Introduction
Subjects
Clinical records of all children born between 1991
and 2001 with the diagnosis of CDH and referred to the
University Children’s Hospital Zurich were reviewed ret-
rospectively. Data collected included gestational age,
gender, birth weight, Apgar score, duration of assisted
ventilation, age at surgery and length of hospitalisation.
Five patients with chromosomal aberration as well as 
four patients with diaphragmatic relaxation or Morgagni
hernia were excluded.
The Medical Ethics Committee of the University
Hospital Zurich approved the study and written informed
consent was obtained prior to testing from all parents. 
Long-term follow-up
A questionnaire pertaining to respiratory symptoms
in the first three years of life, history of asthma and al-
lergy, gastroesophageal reflux requiring pharmacological
treatment or surgery at any time and parental smoking
was given to patient’s parents. 
A physical examination was performed in all chil-
dren by the same investigator. Each patient’s growth was
assessed and compared with the standard growth curve of
Swiss children.
After the clinical examination, the patient underwent
pulmonary function testing in the following order: nitric
oxide measurement, spirometry and body plethysmogra-
phy, measurement of airway impedance using a forced os-
cil lation technique and finally a methacholine bronchial
provocation test. 
Exhaled nitric oxide
Exhaled nitric oxide was measured on-line using the
single-breath technique by means of a chemiluminescence
analyser (CLD 88 EXHALYZER, ECO MEDICS AG,
Switzerland). Measurements were made according to Eu-
ro pean Respiratory Society (ERS) guidelines. 
Lung function
Spirometry and whole body plethysmography were
performed according to standardised criteria using the
meas urement unit MasterLabPro ( Jaeger GmbH, Würz -
burg, Germany). 
The following parameters were recorded: forced
vital capacity (FVC), forced expiratory volume in first
second (FEV1), peak expiratory flow (PEF), FEV1/FVC
ratio, maximum expiratory flow at 75%, 50% and at 25%
FVC (MEF75, MEF50, MEF25) and MEF75–25 ratio. The
reference values from Zapletal et al. [9] were used for
analysis. 
Whole body plethysmography was performed in 
the same laboratory (MasterLabPro, Jaeger, Würzburg,
Germany). The following parameters were recorded: 
Total lung capacity (TLC), residual volume (RV),
vital capacity (VC), intra-thoracic gas volume (ITGV),
total resistance (R tot), total specific airway resistance 
(SR tot), RV%/TLC ratio, and ITGV%/TLC ratio. 
Bronchial hyper-responsiveness
The bronchial provocation test with methacholine
(MCH) was performed, when the baseline FEV1/VC
ratio was at least 0.7. MCH was given in doubling concen -
tration of 0.01 mg/ml to 2 mg/ml using a calibrated neb-
ulizer and FEV1 was measured after each dose-step until
the FEV1 value had fallen from baseline by at least 20%. 
Forced oscillation 
The impedance of the total respiratory system was
measured using an oscillometry system (Quark i2m
Forced Oscillation Measurement system, Chess medical
technology, NV). Three reproducible measurements
were selected for the analysis in order to calculate a mean
value for the resistance of the respiratory system at 8 Hz
(Rrs 8), which is considered to be highly associated with
bronchial obstruction. The results were compared to the
reference values supplied by manufacturer [10].
Statistical analysis
Results are expressed as mean (SD) for continuous
data or median with range. Continuous data from CDH
survivors and non-survivors as well as questionnaire data
taken at follow-up visit were tabulated and described as
numbers. Lung function data were described as percent
predicted. The relationship of the most important data is
shown using scatter plots, the corresponding coefficient
of correlation is also given.  
Materials and methods
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Patient presentation and initial management
During the ten-year period, 46 patients with
CDH were admitted to the University Children’s
Hospital Zurich. Demographic data of all patients
are shown in table 1. 
Thirty (65%) children survived to discharge
from the hospital. Median age at surgery was 4 days
[2 and 21 days]. In the group of survivors, 17/30
(57%) children were operated within 96 hours of
presentation. The median for duration of artificial
ventilation in the group of survivors was 12 days
[1 and 162 days]. Neither gestational age nor Apgar
score at five minutes correlated with intubation
length (fig. 1).
Follow-up
From the 30 survivors, eleven children were
either lost to follow-up or refused consent to the
study. The remaining 19 (63%) were recruited to
attend the long-term follow-up. Mean (SD) age 
at follow-up was 8.2 (2.8) years. The patient char-
acteristics of survivors, those who died and the
children included in the follow-up study are pre-
sented in table 1. 
Questionnaire
A review of questionnaires revealed that res-
piratory problems occurred most commonly in
the first three years of life. At least one wheezy
episode requiring bronchodilators was present in
8/19 (42%) children during this period. Recurrent
wheezing episodes (3/year) in the first three years
of life were reported by parents of 4/19 (21%)
children. The duration of artificial ventilation,
ICU- hospitalisation length and total hospitali -
sation length did not correlate with recurrent res-
piratory symptoms later in childhood. In two chil-
dren the diagnosis of allergic bronchial asthma was
established. Smoking occurred in 6/19 (30%) of
the households. 5 of 6 CDH patients postnatally
exposed to tobacco smoke were using bronchodila -
tors in the year previous to follow-up (r2 = 0.49).
Results 
Table 1
Patient characteristics and initial management according to outcome and to participation in the study. Continuous variables are summarised 
by either the mean (SD) or the median [range].
Died CDH survivors CDH survivors CDH survivors 
as a whole group participated in the study lost from follow-up
Number 16 (11 male) 30 (16 male) 19 (11 male) 11 (5 male)
Gestational age, weeks 38 [33, 42] 38 [30, 42] 38 [30, 42] 39 [33, 41]
Birth weight, g 3100 [1700, 4250] 3000 [2250, 3900] 3000 [2400, 3900] 3000 [2250, 3900] 
5 minute Apgar score 6 (2) 7 (1) 7 (1) 6 (1)
Side of CDH
Right 2 2 1 1
Left 16 30 19 11
Day of surgery * 5 [2, 21] 5 [2, 21] 5 [2, 17]
Duration of 3 [1, 195] 12 [2, 120] 7 [2, 33] 15 [2, 120]
artificial ventilation, days
Length of ICU 3 [1, 195] † 16 [2, 133] 13 [2, 133] 18 [4, 128]
Hospitalisation, days
Total Hospitalisation 3 [1, 195] † 30 [10, 156] 30 [12, 145] 30 [10, 156]
Length, days
* 13/16 of non-surviving CDH patients succumbed to respiratory failure before a surgical intervention could be performed.
† all patients died on ICU.
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Figure 1
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sus gestational age
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5 minutes.
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The family history (first degree) for an atopic
disease was positive in 8/19 (42%) cases. 
GER requiring pharmacological treatment was
present in 3/19 (16%) children and one child un-
der went Nissen fundoplication. The questionnaire
data are summarised in table 2. 
Clinical examination 
Mild to moderate developmental delay was
present in two children. These patients were not
able to perform the lung function tests reliably. 
Height values were within normal range in all
children, and only two children presented with a
body weight below the 3rd percentile. 
Lung function 
16 children performed a reproducible and 
acceptable forced vital capacity manoeuvre,
whereas acceptable whole body plethysmography
tests were obtained in only 11 children, aged 6 to
13 years.
As a whole group, the CDH patients showed
a mild reduction in the majority of measured pa-
ra meters compared to predicted values (table 3).
The individual analysis of measured parame-
ters showed normal values in only 7/16 (44%)
sub jects. Four children had restrictive pulmonary
dis ease; four had evidence of airflow limitation
and one child showed a mixed pattern of pul-
monary disease.
Correlation between lung function results
and patient characteristics
The spirometric parameters (FVC, FEV1,
FEV1/FVC, MEF75, MEF50, MEF25 and
MEF75–25), did not correlate with either gesta-
tional age, birth weight or 5 minute Apgar score
(for example, fig. 2).
Neither duration of assisted ventilation nor
the ICU hospitalisation length and total hospital-
isation length showed any significant correlation
with spirometric parameters (fig. 3). 
Similar figures, i.e. no significant correlations,
were found for plethysmographic parameters.
Positive familial history of atopy or asthma
and tobacco smoke exposition did not significantly
affect the measured lung function parameters.
Measurement of exhaled nitric oxide (eNO)
Mean value of eNO for the whole group was 11
(12) ppb. The highest eNO value, 58 ppb, was ob-
tained in a child with bronchial asthma and allergy.
The remaining patients had eNO levels be-
tween 2 and 15.2 ppb, which was considered
176The pulmonary outcome of long-term survivors after congenital diaphragmatic hernia repair
Table 2
Data from question-
naire regarding 
the respiratory prob-
lems and gastro -
esophageal reflux as
reported by parents
of the CDH survivors
(N = 19) at follow-up
visit.
N %
Family history of atopy 9 47
Family history of asthma 5 26
Current asthma 2 10
At least 1 episode of obstructive breathing 9 47
Recurrent wheezing or persisted cough 4 21
Tobacco smoke exposition 6 32
Smoking (mother) during pregnancy 1 5
Past history of GER* in early childhood 4 21
Fundoplication 1 5
GER symptoms in last 12 months 1 5
Bronchodilator therapy in last 12 months 9 47
* Gastroesophageal reflux requiring pharmacological 
or surgical therapy.
Table 3
Pulmonary Function
Testing at follow-up
visit.
Body plethysmography (N = 11)
Total Lung Capacity (TLC) 93 (20)
Vital Capacity 75 (18)
Intrathoracic Gas Volume (ITGV) 107 (23)
Residual Volume (RV) 131 (67)
RV/TLC 136 (63)
ITGV/TLC 110 (41)
Resistance total 175 (47)
Specific Resistance total 227 (102)
Spirometry (N = 16)
Forced Vital Capacity (FVC) 67 (19)
Forced Expiratory Volume in 1st second (FEV1) 74 (21)
FEV1/FVC 109 (8)
Peak Expiratory Flow 67 (24)
Mean Expiratory Flow at 75% 
of Vital Capacity (MEF75) 66 (27)
Mean Expiratory Flow at 50% 
of Vital Capacity (MEF50) 68 (34)
Mean Expiratory Flow at 25% 
of Vital Capacity (MEF25) 69 (48)
MEF75–25 68 (37)
Values shown are means of percent-predicted (SD) except 
for RV/TLC, ITGV/TLC and FEV1/FVC, which are defined 
as percent.
0 1 2 3 4 5 6 7 8 9 10
R2 = –0.39
 
R2 = 0.34
140
120
100
80
  60
40
020
0
140
120
100
080
60
40
20
0
0 500 1000 1500 2000 2500 3000 3500 4000 4500
Figure 2
FEV1 versus Apgar score at 5 minutes and birth weight.
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within normal limits. No significant correlation
was found between eNO on the one hand and a
family history of asthma or allergy, tobacco smoke
exposition, history of GER or recurrent wheezing
episodes in the first year of live on the other hand.
Similarly, the duration of assisted ventilation and
total hospi talisation time did not correlate with
eNO (fig. 4).
Methacholine bronchial provocation test 
Only eight patients correctly completed the
bronchial challenge test. Inhalation of metha-
choline resulted in a 20% or more decrease of
FEV1 in 6/8 (75%) children. 
All the patients with positive methacholine
bronchial provocation test had eNO values be-
tween 1.8 and 11.1 ppb.
Measurement of resistance using the forced
oscillation technique
15 children successfully performed the FOT
measurement. 9/15 (60%) children showed in-
crea sed resistance measured at 8 Hz (Rrs 8). The
dura tion of artificial ventilation, ICU hospitalisa-
tion time and total hospitalisation time did not
correlate with the Rrs 8 (fig. 5). 
Similarly, no significant correlation was found
for Rrs 8 and family history of allergy or asthma,
recurrent respiratory symptoms or eNO. Six chil-
dren with increased Rrs 8 also had abnormal lung
function in spirometry. Two other children with
increased Rrs 8 but normal spirometry had al-
ready been exposed to tobacco smoke prenatally
and had received bronchodilator therapy in the
year prior to the follow-up visit. We found no cor-
relation be tween oscillatory resistance and the
specific airway resistance measured by whole
body plethysmography.  
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The overall mortality rate of 35% in our study
is similar to that reported from other tertiary care
paediatric centre-based studies [11]. It is well
known that some live-born infants with CDH die
before referral to a tertiary centre. Consequently,
the population of infants reaching a tertiary care
centre commonly represents only 40–50% of the
total number of cases of CDH. This disparity re-
flects the “hidden mortality” of CDH as first de-
scribed by Harrison et al. [12]. Due to a well-de-
veloped prenatal screening programme in Switzer-
land it can be assumed that the overall mortality of
CDH patients calculated on behalf of a popula-
tion-based study would be twice as high [13]. 
The limited number of patients (63% of all
survivors) who underwent follow-up assessment is
a potential weakness of the study. As shown in
table 1, there was only a minimal difference in
most of the descriptive parameters of CDH sur-
vivors who participated in the study and those who
were lost to follow-up. Recent studies have shown
that gastroesophageal reflux is commonly found in
survivors of CDH [14]. The reported incidence of
GER depends partially on the diagnostic methods
used. Using a questionnaire we found symptoms
consistent with GER requiring pharma cological
or surgical therapy beyond the neo natal period in
four patients. Recurrent bronchitis, aspi ration
pneumonia and worsening pulmo nary function
were reported as respiratory complications of GER.
Anti-reflux surgery is reserved for pathologic GER
that persists despite maximisation of medical ther-
apy. In our study group, only one patient required
a Nissen fundoplication. Failure to thrive is fre-
quently described in CDH survivors. The relative
low incidence of GER and of severe pulmonary
impairment could explain the low incidence of
failure to thrive in our group of patients. 
Many studies report a high incidence (>60%)
of chronic lung disease initially [15, 16] with im-
provement in most children with CDH repair
during the first few years of life. The same trend
was noted in our study. 8/19 (42%) of the children
followed up presented with wheezy episodes early 
in life. Respiratory symptoms became less com-
mon and milder as patients grew older, neverthe-
less 8/19 (42%) patients had received bron-
chodilator therapy in the year prior to the follow-
up. 2/19 (10%) children were diagnosed as having
bronchial asthma. This corresponds well with the
0
0
20
40
60
80
100
120
140
20 40 60 80 100 120 140
R 2 = –0.20
0
20
40
60
80
100
120
140
0 20 40 60 80 100 120 140 160
R 2 = –0.26
FEV1 versus ICU hospitalisation length
FEV1 versus total hospitalisation length
ICU hospitalisation length (days)
Total hospitalisation length (days)
Figure 3
FEV1 versus 
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overall incidence of childhood asthma in Switzer-
land (8%). 
The follow-up group of CDH patients in our
study represented 63% of all survivors. It is a not
un known phenomenon that parents of more se-
verely ill children are more likely to refuse to par-
ticipate in studies than those of less severely af-
fected children. As shown in table 1, the CDH
survivors who were lost to follow-up had a
slightly prolonged duration of artificial ventila-
tion and prolonged hospitalisation time. It is pos-
sible that had these patients been included in the
analysis we would have seen a higher incidence of
respiratory problems. 
In the last years, several studies looking at lung
function outcomes in children surviving congenital
diaphragmatic hernia have been performed [17,
18]. In the present series, we found various degrees
of obstructive or restrictive ventilatory impair ment
in 50% of the patients, a figure comparable with
results from other studies [19, 20]. We typically ob-
served lowering of functional lung volumes with a
tendency to hyperinflation. Interstitial emphysema
[21], increased airway collapsibility and decreased
compliance of chest wall or diaphragm may be re-
sponsible for these functional changes. 
In our study sample, lung function parame-
ters were not predicted by perinatal factors. Con-
trary to other, larger studies [20] we found no sig-
nificant correlation for lung function parameters
and duration of artificial ventilation. The only
weak trend showing increasing lung function im-
pairment, i.e. smaller FEV1, depending on the
length of intubation, could be the result of the
small sample size in our study. 
We are aware that there is a significant limita-
tion due to the small number of patients who cor-
rectly performed the methacholine provocation test
in our study. In consequence, we do not attempt
to draw any conclusion on the basis of this data
and we present the data in a descriptive way only. 
This is the first follow-up study in CDH to in-
clude a measurement of respiratory system resist-
ance using a forced oscillation technique. Our aim
was to assess the ability of the forced oscillation
technique to detect the alterations in the respira-
tory mechanics in CDH patients. There are many
studies addressing respiratory mechanics in lung
disease in childhood [22, 23] suggesting that FOT
detects abnormal airway resistance more periph-
erally in the lung and hence may give more infor-
mation about the peripheral airways as compared
to spirometry. The fact that 9/15 (60%) of CDH
patients had an increased resistance measured at 
8 Hz and that six of these children also had an ab-
normal spirometry pattern may suggest symmet-
rical involvement of both small and large airways.
This type of abnormal lung mechanics could be
explained by lung and bronchial tree hypoplasia. 
There are no data on exhaled nitric oxide
(eNO) at long-term follow-up in children with
CDH. Epithelial cells of the bronchi have been
identified as the main source of exhaled nitric oxide
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and abnormal values for eNO have been reported
in many respiratory conditions. Patients with bron-
chopulmonary dysplasia (BPD) have been studied
in regard to exhaled nitric oxide (eNO). Baraldi et
al. [24] found eNO values in school-age survivors
of BPD to be four times lower compared with a
group of patients with asthma with a comparable
airflow limitation. Others have found normal val-
ues for eNO in non-atopic schoolchildren with a
history of BPD [25]. The duration of artificial
ventilation and oxygen therapy in CDH patients
is in many cases comparable to that in BPD pa-
tients and dysplasia of the bronchial tree has often
been described in CDH survivors. Hence, CDH
survivors represent a group of patients with poten -
tially abnormal airway nitric oxide production.
Analysed as a whole group, we found normal
values for exhaled nitric oxide. Exhaled NO is
presently recognised as a marker of airway inflam -
mation and is related to bronchial hyper-respon-
siveness in asthmatic patients [26]. Therefore, one
may hypothesize that reasons other than airway
inflammation are responsible for the bronchial
hyper- responsiveness seen in many of the CDH
survivors. The reduced spirometry parameters in
context with normal eNO values seen in our group
of CDH survivors may indicate that the lung func-
tion impairment has a structural rather than an
inflammatory origin. 
In conclusion, the results of follow-up assess-
ments presented are in agreement with other
pub lished studies and demonstrate a good general
prognosis for surviving CDH patients. Children
who survived CDH repair have reduced functio -
nal lung volumes but normal TLC. Exhaled nitric
oxide in non-atopic CDH survivors is normal.
FOT can be used as a screening method to detect
CDH survivors with abnormal spirometry para -
meters. Even in the absence of clear clinical signi -
ficance, the incomplete functional recovery of the
lung in CDH survivors and the risk of neurode-
velopmental and nutritional morbidity require
long-term follow-up in a paediatric centre. This
follow-up should include a multidisciplinary team
consisting of paediatric surgeons, neonatologists,
paediatric pulmonologists, paediatric orthopaedic
specialists, gastroenterologists, dieticians and car-
diologists. 
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